ISPOR 17th Annual International Meeting
June 2-6, 2012, Washington, DC, USA
Search:
Value-based Decision Making in Rheumatic Disease : What does it mean for pharmacists ?
Médicaments Issus des Biotechnologies : Différencier Les Prix selon la Valeur
Comments on : Performance-Based Risk-Sharing Arrangements - Good practice for design, implementation and evaluation. An ISPOR Task force review
EUnetHTA : Draft Guidelines - Endpoints used for REA of pharmaceuticals HEALTH-RELATED QUALITY OF LIFE and UTILITY MEASURES
Home
Conferences
European Respiratory Society Annual Congress
September 2-6, 2006, Munich, Germany.
Abstract submission deadline : February 23, 2006. For more information :
http://www.ernest.org
Value-based Decision Making in Rheumatic Disease : What does it mean for pharmacists ?
